in vivo investigation of KOR as a marker of BPD and suicide related endophenotypes
KOR 作为 BPD 和自杀相关内表型标志物的体内研究
基本信息
- 批准号:10735604
- 负责人:
- 金额:$ 80.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-20 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAffectAffectiveAggressive behaviorAnimalsAnti-Anxiety AgentsAntidepressive AgentsAreaAttentionAutopsyBindingBorderline Personality DisorderBrainBrain imagingChronicChronic stressClinicalClinical TrialsDataDepressed moodDevelopmentDiagnosticDiseaseDissociationDistressDopamineDown-RegulationDynorphinsFunctional disorderFundingFutureGeneral PopulationGoalsHumanHydrocortisoneImaging TechniquesImpaired cognitionImpulsivityIncidenceIndividualInsula of ReilInterventionInvestigationLifeLinkLow PrevalenceMagnetic Resonance ImagingMolecularMolecular TargetMorbidity - disease rateNeurobiologyOpioidOpioid AntagonistOpioid PeptidePainParticipantPeripheralPharmaceutical PreparationsPlayPositron-Emission TomographyPreventionPrognosisRecording of previous eventsRegulationResearchResistanceRiskRisk ReductionRoleSelf-Injurious BehaviorSerotoninSeveritiesSex DifferencesSocial FunctioningStressSuicideSuicide attemptSymptomsSystemTechniquesTestingTreatment outcomeUnderserved PopulationWomanWorkabuse liabilitybeta-Endorphinclinically relevantdisorder riskdrug of abuseeffective therapyemotion dysregulationemotion regulationendogenous opioidsendophenotypeepidemiology studyexperiencefallshigh riskhigh risk populationimaging studyin vivoinnovationinsightkappa opioid receptorsmalemenmortalitymu opioid receptorsnovelopioid mortalitypain perceptionpharmacologicpre-clinicalpreclinical studypsychiatric symptomradioligandradiotracerreceptor expressionreceptor-mediated signalingreduce symptomsreducing suicideresponsesexsocialstress related disordersuicidalsuicidal behaviorsuicidal morbiditysuicidal risksuicide mortalitysymptom treatmentsymptomatologytargeted agenttherapy developmenttreatment risk
项目摘要
PROJECT SUMMARY
The goal of this study is to investigate the role of the kappa opioid receptor (KOR) in the symptomatology
of borderline personality disorder (BPD), a condition associated with alarmingly elevated risk for suicide
attempt (SA; up to 75%) and death by suicide (up to 10%). Despite BPD’s relatively low prevalence (1-5%),
epidemiological research has shown that up to 33% of suicide deaths in the general population are attributable
to BPD. Adding complexity, research suggests that significant sex differences exist in BPD with respect to both
symptoms’ presentation and neurobiology; BPD males have higher suicide risk, but less access to effective
treatment. Despite this, available treatments are largely not capable of addressing overall BPD symptom
severity or rapidly reducing suicide risk. Magnetic resonance imaging (MRI) studies have identified structural
and network alterations in BPD and have associated structural differences and dysregulation in a frontolimbic
circuit of regions with incidence of BPD and increased symptom severity, and suicidal behavior in BPD.
Investigation of molecular mechanisms responsible for BPD symptoms, and suicide risk specifically, is an
essential next step to both promote development of novel treatments and facilitate risk prevention in BPD.
Emerging evidence implicates KOR in BPD and suicidal behavior. KOR plays critical roles in emotion
regulation, social functioning, and impulsivity– all of which are both central to BPD and related to suicide risk.
Postmortem studies have shown an association between KOR and death by suicide. Further, a variety of
studies in both animals and humans have shown that KOR antagonists can produce antidepressant, anxiolytic,
and even anti-suicidal effects, though research also suggests men and women may respond differently to such
agents. Importantly, KOR agents’ effect on dopamine is modest relative to drugs of abuse, reducing concerns
about abuse potential. Based on support from novel pilot data using the same techniques, we now propose a
novel investigation of KOR availability in individuals with BPD relative to healthy adults (HA) using positron
emission tomography (PET), a brain imaging technique, and radioligand [11C]EKAP which binds selectively to
KOR in the brain (Aim 1a). We will also evaluate the association between KOR availability and SA history in
BPD (Aim 1b). Next, we will evaluate the association between impulsivity, emotion dysregulation, and BPD
symptom severity – key endophenotypes related to prognosis and suicide risk and resistant to treatment – and
KOR availability in BPD (Aim 2). Finally, we will evaluate sex differences in KOR availability in BPD and HA.
Results of this study will provide potentially critical insight into the relationship between this novel molecular
target, BPD symptom presentation, and suicidal behavior. Based on findings we will pursue funding for a larger
PET study to test potential non-addictive KOR targeted medications for both overall BPD symptom reduction,
and suicide risk.
项目概要
本研究的目的是调查 kappa 阿片受体 (KOR) 在症状学中的作用
边缘性人格障碍(BPD),一种与自杀风险惊人升高相关的疾病
自杀未遂(SA;高达 75%)和自杀死亡(高达 10%)。尽管 BPD 的患病率相对较低(1-5%),
流行病学研究表明,普通人群中高达 33% 的自杀死亡归因于自杀
到 BPD。研究表明,BPD 中存在显着的性别差异,这增加了复杂性。
症状表现和神经生物学; BPD 男性自杀风险较高,但获得有效治疗的机会较少
治疗。尽管如此,现有的治疗方法很大程度上无法解决 BPD 的整体症状
严重程度或迅速降低自杀风险。磁共振成像(MRI)研究已经确定了结构
和 BPD 中的网络改变,并与额边缘的结构差异和失调相关
BPD 发病率和症状严重程度增加的区域的循环,以及 BPD 中的自杀行为。
研究造成 BPD 症状、特别是自杀风险的分子机制是一项重要的研究工作。
下一步是促进新型治疗方法的开发和促进 BPD 风险预防的重要一步。
新出现的证据表明 KOR 与 BPD 和自杀行为有关。 KOR 在情感中发挥着关键作用
调节、社会功能和冲动——所有这些都是 BPD 的核心,并且与自杀风险相关。
尸检研究表明 KOR 与自杀死亡之间存在关联。此外,各种
对动物和人类的研究表明,KOR 拮抗剂可以产生抗抑郁、抗焦虑、
甚至还有抗自杀作用,尽管研究也表明男性和女性对此的反应可能不同
代理。重要的是,与滥用药物相比,KOR 药物对多巴胺的影响较小,从而减少了担忧
关于滥用的可能性。基于使用相同技术的新颖试点数据的支持,我们现在提出了
使用正电子对 BPD 患者相对于健康成人 (HA) 的 KOR 可用性进行新研究
发射断层扫描 (PET)(一种脑成像技术)和选择性结合的放射性配体 [11C]EKAP
大脑中的 KOR(目标 1a)。我们还将评估 KOR 可用性与 SA 历史记录之间的关联
BPD(目标 1b)。接下来,我们将评估冲动、情绪失调和 BPD 之间的关联
症状严重程度——与预后、自杀风险和治疗耐药相关的关键内表型——以及
BPD 中的 KOR 可用性(目标 2)。最后,我们将评估 BPD 和 HA 中 KOR 可用性的性别差异。
这项研究的结果将为这种新型分子之间的关系提供潜在的重要见解。
目标、BPD 症状表现和自杀行为。根据调查结果,我们将为更大的项目寻求资金
PET 研究旨在测试潜在的非成瘾性 KOR 靶向药物,以减少整体 BPD 症状,
和自杀风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret Taylor Davis其他文献
Margaret Taylor Davis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret Taylor Davis', 18)}}的其他基金
Preliminary in vivo investigation of the opioid system in borderline personality disorder
边缘性人格障碍中阿片类药物系统的初步体内研究
- 批准号:
10317111 - 财政年份:2020
- 资助金额:
$ 80.56万 - 项目类别:
Dysregulation in mGluR5 as a marker of BPD and suicide related endophenotypes
mGluR5 失调作为 BPD 和自杀相关内表型的标志
- 批准号:
10450146 - 财政年份:2018
- 资助金额:
$ 80.56万 - 项目类别:
Dysregulation in mGluR5 as a marker of BPD and suicide related endophenotypes
mGluR5 失调作为 BPD 和自杀相关内表型的标志
- 批准号:
10224000 - 财政年份:2018
- 资助金额:
$ 80.56万 - 项目类别:
Dysregulation in mGluR5 as a marker of BPD and suicide related endophenotypes
mGluR5 失调作为 BPD 和自杀相关内表型的标志
- 批准号:
9582281 - 财政年份:2018
- 资助金额:
$ 80.56万 - 项目类别:
Dysregulation in mGluR5 as a marker of BPD and suicide related endophenotypes
mGluR5 失调作为 BPD 和自杀相关内表型的标志
- 批准号:
9977813 - 财政年份:2018
- 资助金额:
$ 80.56万 - 项目类别:
Dysregulation in mGluR5 as a marker of BPD and suicide related endophenotypes
mGluR5 失调作为 BPD 和自杀相关内表型的标志
- 批准号:
9756464 - 财政年份:2018
- 资助金额:
$ 80.56万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 80.56万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 80.56万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 80.56万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 80.56万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 80.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 80.56万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 80.56万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 80.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 80.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 80.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




